Document Detail


Recurrent laryngeal nerve monitoring: state of the art, ethical and legal issues.
MedLine Citation:
PMID:  19836490     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Despite many advances in surgical techniques during the last several decades, the risk for recurrent laryngeal nerve (RLN) injury during thyroid and parathyroid surgery has only declined, not disappeared. RLN monitoring is an attempt to reduce the risk of nerve injury during thyroid and parathyroid surgery. In this article, the author discusses how to use RLN monitoring, its effectiveness, and the options available. He also highlights potential legal and ethical issues that surround the use of this method.
Authors:
Peter Angelos
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Surgical clinics of North America     Volume:  89     ISSN:  1558-3171     ISO Abbreviation:  Surg. Clin. North Am.     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2009-10-19     Completed Date:  2009-12-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0074243     Medline TA:  Surg Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1157-69     Citation Subset:  AIM; IM    
Affiliation:
Section of General Surgery and Surgical Oncology, MacLean Center for Clinical Medical Ethics, University of Chicago, Chicago, IL 60637, USA. pangelos@surgery.bsd.uchicago.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Intraoperative Complications / prevention & control
Liability, Legal
Monitoring, Physiologic / ethics,  methods*
Parathyroid Diseases / surgery*
Parathyroidectomy / adverse effects*
Recurrent Laryngeal Nerve / injuries*
Thyroid Diseases / surgery*
Thyroidectomy / adverse effects*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Molecular markers in thyroid cancer diagnostics.
Next Document:  Surgical management of well-differentiated thyroid cancer: state of the art.